| Status | Proposed |
| Process | STA 2018 |
| ID number | 1087 |
Provisional Schedule
| Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators | 06 August 2019 - 04 September 2019 |
Project Team
| Project lead | Michelle Adhemar |
Email enquiries
- If you have any queries please email scopingta@nice.org.uk
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 22 October 2018 | The company that is developing fostamatinib have shared confidential information with NICE. As a result the Institute will not be progressing with the scoping exercise at this current time. Consequently the consultation on the draft scope will now be closed early. If you have any comments or concerns please contact the project manager for this proposed appraisal Emily Richards on (44 (0)161 413 4070 or via email on emily.richards@nice.org.uk |
For further information on how we develop guidance, please see our page about NICE technology appraisal guidance